Nisa Leung

Nisa Leung has been the director since 2014.

Ms. Leung is a Managing Partner at Qiming Venture Partners, where she leads its health care investments. In addition to serving on the board of directors, Ms. Leung is also a member of the board of directors of CanSino Biotechnology, a vaccine developer; dMed, a Shanghai-based CRO consulting startup; Gan & Lee Pharmaceuticals, a developer of insulin analog; Nurotron Biotechnology, a developer of neurostimulation systems; and Venus Medtech, a developer of interventional artificial cardiac valve systems.

Ms. Leung received a Master of Business Administration from the Stanford Graduate School of Business.